Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12086153 | 1.00 | DAO (0.32) | DAOCA3CA6CA5ACA9 | |
| SCHEMBL2725212 | 0.91 | ALDH1A1 (0.35) | DAOALDH1A1 | |
| SCHEMBL12086070 | 0.91 | ALDH1A1 (0.35) | DAOALDH1A1 | |
| SCHEMBL12086131 | 0.87 | DAO (0.33) | DAO | |
| SCHEMBL2937598 | 0.87 | KDM4E (0.32) | DAO | |
| SCHEMBL12086191 | 0.87 | KDM4E (0.32) | DAO | |
| SCHEMBL12086108 | 0.87 | DAO (0.32) | DAO | |
| SCHEMBL2734410 | 0.87 | DAO (0.32) | DAO | |
| SCHEMBL2712753 | 0.87 | — | — | |
| SCHEMBL2709938 | 0.86 | KDM4E (0.37) | CA3CA6CA5ACA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYP2F1, FLAD1, AFF1 | DAO 625/4885CA3 770/4885CA6 1785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.